Anavex director Axel Paeger files Form 3

ANAVEX LIFE SCIENCES CORP. director Axel Paeger filed an initial Form 3, which is a statement of beneficial ownership for company insiders.

Rhea-AI Filing Summary

ANAVEX LIFE SCIENCES CORP. director Axel Paeger filed an initial Form 3, which is a statement of beneficial ownership for company insiders. The filing shows no reported transactions, exercises, gifts, or restructurings and contains no derivative holdings or position details in this excerpt.

Key Terms

Form 3, beneficial ownership, netBuySellDirection

3 terms

Form 3 regulatory

"INSIDER FILING DATA (Form 3):"

Form 3 is the initial public filing that officers, directors and large shareholders must submit to report their ownership of a company’s securities when they become insiders. It acts like an opening inventory sheet that gives investors a starting point to see who holds significant stakes and to spot later trades or potential conflicts of interest, helping assess insider confidence and transparency.

beneficial ownership financial

"initial Form 3, which is a statement of beneficial ownership"

Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.

netBuySellDirection financial

""netBuySellDirection": "neutral""

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the ANAVEX (AVXL) Form 3 filing by Axel Paeger mean?

The Form 3 shows director Axel Paeger has filed an initial statement of beneficial ownership in ANAVEX LIFE SCIENCES CORP. It reports no transactions or derivative positions in the provided data, serving as a baseline disclosure of insider status.

Does Axel Paeger buy or sell AVXL shares in this Form 3?

No buy or sell activity appears in this Form 3. The transactionSummary shows zero buys, zero sells, and zero net share changes, indicating the filing only establishes insider reporting status without recording trades.

What insider activity counts are shown for AVXL director Axel Paeger?

The filing lists buyCount, sellCount, exerciseCount, giftCount, and restructuringCount all as zero. netBuySellShares is also zero, with a netBuySellDirection labeled neutral, indicating no reported activity.

Are there any derivative securities reported for Axel Paeger in AVXL?

No derivative securities are shown in the excerpt. The derivativeSummary is empty and derivativeTransactionCount is zero, meaning no options, warrants, or convertible instruments are reported in this Form 3 snapshot.

What role does Axel Paeger have at ANAVEX LIFE SCIENCES CORP.?

The Form 3 identifies Paeger Axel as a director of ANAVEX LIFE SCIENCES CORP. He is not listed as an officer or ten percent owner in the provided data, which shapes his ongoing reporting obligations as an insider.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/01/2026 - 07:18 PM EDT Learn about SEC filing dates

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Paeger Axel

(Last) (First) (Middle)

630 5TH AVENUE, 20TH FLOOR

(Street)

NEW YORK NEW YORK 10111

(City) (State) (Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
02/23/2026

3. Issuer Name and Ticker or Trading Symbol
ANAVEX LIFE SCIENCES CORP. [ AVXL ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

No securities are beneficially owned.

	/s/Alex Paeger	05/01/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)